Jonathan Edwards
Senior Member (Voting Rights)
Not everyone agrees this is a crisis for Cochrane, or more likely - trying to calm the waters?.
From the planet zog, I suspect.
She must like the way things are.
Not everyone agrees this is a crisis for Cochrane, or more likely - trying to calm the waters?.
Long statement from the Cochrane board:
https://www.cochrane.org/news/statement-cochranes-governing-board
I've not read all of it, but it looks like they go after Gøtzsche hard:
They say bugger all, except that Gotzsche was 'behaving badly'.
The key bit seems to me to be:
All our staff, and our members, have the right to do their work without harassment and personal attacks.
Sounds familiar. Any criticism of standard of science is a personal attack it seems these days. The whole thing looks to be about complaints from staff about not being agreed with.
They have provided no reason whatever for an onlooker to think they have a justified reason for excluding G. G may be a nutcase for all I know but that is beside the point.
The phrasing in Cochrane looks like a poor attempt at manipulation.
the Board came to a decision to invoke Article 5.2.1. relating to termination of membership. This was not unanimous. As a result, Article 5.3 was triggered, and the member has been invited to make a written response within seven days.
At this point in time, this person remains a member of the Cochrane Collaboration.
I can see why he was thrown out of Cochrane
I can see why he was thrown out of Cochrane
He has often been critical of Cochrane as well. In a statement written for his 2017 election to the board, Gøtzsche listed a litany of "pretty widespread concerns" he wanted to address, including the concentration of power at the Central Executive Team in London and the fact that "collaboration" had been dropped from the group's name. "The Cochrane Collaboration is now run much more as a business with a brand than it was just a few years ago," he wrote.
Yet Cochrane policy, renewed again in 2014, still allows individuals with financial ties to pharmaceutical companies to review evidence about those same companies’ products—if they constitute a minority of the review team.
They have provided no reason whatever for an onlooker to think they have a justified reason for excluding G. G may be a nutcase for all I know but that is beside the point.
Not in the scientific world (although impact counts, too) - of course depending on the field: in physics quantity was all (chemistry, too, from what I have seen), in maths it was more quality...It's not good in my opinion.but one good paper in a whole career is better than 800 dubious ones
It seems Gøtzsche is still leader for the Nordic Cochrane Center.
Ugeskriftet: Magtkampen i Cochrane afgjort - for nu
Google translate The power battle in Cochrane is over - for now